Preparing for the upcoming respiratory season
October 2021 – Repertoire Magazine
BD is prepared for whatever respiratory season may lay ahead. With the addition of the company’s newest combined COVID-19 & Flu assay, BD is building a robust inbound pipeline for all five of the BD VeritorTM Plus assays so customers can meet the needs of their communities.
While COVID-19 testing should remain a priority for healthcare providers during the 2021-2022 flu season, the CDC has predicted that “reduced population immunity due to lack of flu virus activity since March 2020 could result in an early and possibly severe 2021-2022 flu season.” Additionally, the CDC has warned providers that it has observed concerning levels of RSV developing in the U.S. South.
The symptoms of influenza and COVID-19 are nearly identical, which can be a challenge to diagnose based solely on clinical presentation. Launched in August, BD’s combined SARS-CoV-2 & Flu A+B assay provides three results from a single sample on one assay, all in just 15 minutes. The assay, available for the BD VeritorTM Plus Analyzer, can help clinicians to quickly and clearly differentiate between COVID and influenza as we enter the new respiratory season.
The newly expanded testing menu for the BD VeritorTM Plus System allows caregivers to easily bring in additional tests without a tremendous learning curve because the workflows are all so similar. Best of all, the Analyzer provides clear, unambiguous digital results, eliminating interpretation and enabling accurate diagnosis and treatment.
BD has recently partnered with ImageMover, a result management companion app that allows caregivers to input and manage patient records, notify patients of their results, and automatically report SARS-CoV-2 results to state health authorities. BD is providing complimentary access to all BD VeritorTM users.
The great thing about BD VeritorTM is its simplicity and versatility. From the ER to a school nurse’s office, and everywhere in between, the system provides reliable, rapid results onsite. In these non-acute spaces, ImageMover really shines as a seamless result record and reporting solution.
Product Assurance
The upcoming respiratory season may be unpredictable, but BD is firing on all cylinders to make sure that your customers can rest easy without having to worry about possible shortages at inopportune times.
By working closely with its distribution partners, BD is able to maintain constant inbound supply to meet current needs.
On top of that, BD continues to invest in its robust global supply chain. In order to support the unique needs of their customers BD is continuing to manufacture additional inventory for all five assays offered on the BD VeritorTM Plus System and pushing millions of tests into the marketplace weekly.
For more information reach out to your BD rep, or visit http://bdveritor.com .
BD Products Available for the 2021-22 Respiratory Season:
The five assays offered on the BD Veritor Plus System currently are:
1. SARS-CoV-2/Flu (COVID & Flu Combo Assay)
2. SARS-CoV-2 (COVID Only Assay)
3. Flu A+B (Influenza Only Assay)
4. Group A Strep (GAS)
5. Respiratory Syncytial Virus (RSV)
The company is also running a variety of seasonal promotions that provide customers added savings such as free instruments or test kits when purchasing kits. These kits require a CLIA Certificate of Waiver.